Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
First Claim
1. A method of treating or reducing the recurrence of small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject, comprising:
- providing a pharmaceutically acceptable composition comprising a serotonin receptor agonist; and
administering the pharmaceutically acceptable composition to said human subject to treat or reduce the recurrence of small intestinal bacterial overgrowth (SIBO) or the SIBO-caused condition.
2 Assignments
0 Petitions
Accused Products
Abstract
Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn'"'"'s disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.
162 Citations
16 Claims
-
1. A method of treating or reducing the recurrence of small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject, comprising:
-
providing a pharmaceutically acceptable composition comprising a serotonin receptor agonist; and administering the pharmaceutically acceptable composition to said human subject to treat or reduce the recurrence of small intestinal bacterial overgrowth (SIBO) or the SIBO-caused condition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A method of treating or reducing the recurrence of irritable bowel syndrome in a human subject, comprising:
-
providing a pharmaceutically acceptable composition comprising prucalopride; and administering the pharmaceutically acceptable composition to said human subject to treat or reduce the recurrence of irritable bowel syndrome. - View Dependent Claims (10, 11)
-
-
12. A method of treating or reducing the recurrence of small intestinal bacterial overgrowth (SIBO) in a human subject, comprising:
-
providing a pharmaceutically acceptable composition comprising a serotonin receptor agonist; and administering the pharmaceutically acceptable composition to said human subject to treat or reduce the recurrence of small intestinal bacterial overgrowth (SIBO). - View Dependent Claims (13, 14, 15, 16)
-
Specification